Orthopedic Shoes Market Poised for Significant Growth Driven by Aging Population and Health Trends

Orthopedic Shoes Market.jpg

According to the newly released data by Future Market Insights (FMI), the global Orthopedic Shoes Market was valued at approximately USD 3,627.0 million in 2022 and is projected to reach an impressive USD 9,070.9 million by 2032, growing at a robust compound annual growth rate (CAGR) of 9.6% from 2022 to 2032.

The demand for orthopedic shoes is primarily driven by an aging population, increasing awareness of health and fitness, and a rising incidence of foot-related ailments, including plantar fasciitis. As more individuals prioritize comfort alongside style, orthopedic shoes are evolving from a mere necessity into fashionable options that cater to diverse consumer preferences.

Key Market Drivers

  • Aging Population: The demand for orthopedic shoes is heavily influenced by the aging demographic in developed nations. As natural shock absorption decreases with age, orthopedic shoes provide essential support and protection.
  • Health and Fitness Trends: The rising focus on health has led athletes and fitness enthusiasts to seek specialized footwear that mitigates injury risk while enhancing performance.
  • Prevalence of Foot Disorders: The increase in foot-related issues like plantar fasciitis—affecting approximately 10% of adults globally—further stimulates market growth as individuals seek effective solutions.

Key Takeaways

  • The Orthopedic Shoes Market is projected for substantial growth driven by an aging population and health trends.
  • The market was valued at approximately USD 3.6 billion in 2022, with expectations to reach USD 9.1 billion by 2032.
  • A CAGR of 9.6% highlights the increasing demand for orthopedic footwear.
  • Key drivers include the rise in foot-related disorders, particularly plantar fasciitis.
  • There is a growing focus on health and fitness, prompting demand for supportive footwear.
  • The industry is evolving from custom orthotics to stylish, affordable options.
  • Men show a higher preference for orthopedic shoes due to active lifestyles and injury risks.
  • Notable mergers, like Orthofeet’s acquisition by Webster Equity Partners, indicate market confidence.
  • Customized orthopedic solutions are gaining traction, catering to specific foot health needs.

Competitive Landscape

During the forecast period, the orthopedic shoe market is expected to be propelled by an increase in treatments for orthopedic disorders.

For Instance

  • In July 2018, Wright Medical Group N.V. unveiled its full line of biologic treatments for the lower limbs, including the injectable bone transplant.
  • According to the National Center for Biotechnology Information (NCBI), 83% of plantar fasciitis patients were working adults between the ages of 25 and 65 in October 2018. This represents a 10% global prevalence. A common foot problem called plantar fasciitis involves the inflammation of the plantar fascia.

Key Companies Profiled

DJO, LLC; DARCO International, Inc.; MEPHISTO S.A.S; Propet US, Inc.; Apex Foot Health Industries, LLC; DUNA-Corradini S.p.A.; Vionic Group LLC; Chaneco Limited; Orthofeet, Inc.; Piedro; Drewshoe Incorporated; New Balance Athletics, Inc; Others

Get Strategic Guidance from Our Analyst Contact us on: +1-347-918-3531

Orthopedic Shoes Market by Category

By Type, Orthopedic Shoes Market is segmented as:

  • Flatfoot Orthopedic Shoes
  • Cavus Orthopedic Shoes
  • Calcaneal Spur Orthopedic Shoes
  • Varus Orthopedic Shoes
  • Valgus Orthopedic Shoes Others

By Application Type, Orthopedic Shoes Market is segmented as:

  • Injuries
  • Alignment Issue
  • Foot disorder

By Consumer Orientation, Orthopedic Shoes Market is segmented as:

  • Men
  • Women
  • Kids

By Sales Channel, Orthopedic Shoes Market is segmented as:

  • Multi-brand Stores
  • Independent Small Stores
  • Online Retailers
  • Other Sales Channel

By Region, Orthopedic Shoes Market is segmented as:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa(MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these